Purchase Order HHSN261201700404P

<p>The National Cancer Institute awarded a purchase order to Genscript USA Inc. valued at $3,964.20 on September 5, 2017, for peptide services. Work is performed in Piscataway, New Jersey. The order carries a firm fixed price structure and ultimate completion date of October 5, 2017.</p>

<p>The National Cancer Institute awarded a purchase order to Genscript USA Inc. for $3,567.96 on August 11, 2017, for peptide services. Work is performed at the awardee's facility in Piscataway, New Jersey. The order is firm fixed price and carries a completion date of September 30, 2017.</p>

<p>The National Cancer Institute awarded a purchase order to Genscript USA Inc. valued at $8,786.64 on August 15, 2017, for peptide services. Work is performed in Piscataway, New Jersey. The order is firm fixed price with an ultimate completion date of September 30, 2017. No set-aside category was applied.</p>

<p>The National Cancer Institute awarded a purchase order to Genscript USA Inc. for $3,633.62 on August 22, 2017. The order is for peptide services and carries no set-aside designation. Work is performed in Piscataway, New Jersey. The purchase order is firm fixed price and concludes September 30, 2017.</p>

<p>The National Cancer Institute awarded a purchase order to Genscript USA Inc. for $3,597.96 on August 29, 2017, for peptide services. Work is performed in San Diego, California. The order is firm fixed price with an ultimate completion date of September 30, 2017.</p>

<p>The National Cancer Institute issued a $5,311.02 delivery order to Genscript USA Inc. on November 3, 2015, for peptide services. Place of performance is Piscataway, New Jersey. The order has a firm fixed price and an ultimate completion date of December 3, 2015.</p>

<p>The National Cancer Institute awarded a purchase order to Genscript USA Inc. for peptide services on August 29, 2017, with a ceiling value of $4,265.34. Work is performed in San Diego, California. The order carries firm fixed price pricing and concludes September 30, 2017.</p>

<p>The National Cancer Institute awarded a purchase order to Genscript USA Inc. for $11,484.18 on August 12, 2019, for sequencing services. Work is performed in Piscataway, New Jersey. The order carries a firm fixed price and is scheduled for completion by September 11, 2019.</p>

<p>The National Cancer Institute awarded a purchase order to Genscript USA Inc. for $11,663.10 on May 28, 2019, to procure custom gene synthesis, custom peptide synthesis, direct cloning, and plasmid services. Work is performed in Piscataway, New Jersey. The order is firm fixed price with an ultimate completion date of June 27, 2019.</p>

<p>The National Cancer Institute awarded a purchase order to Genscript USA Inc. for $12,823.88 on July 24, 2019. The order covers sequencing services at the awardee's location in Piscataway, New Jersey, with an ultimate completion date of August 23, 2019. Pricing is firm fixed price with no set-aside applied.</p>